Antibiotic impregnated catheters and intrathecal antibiotics for CSF shunt infection prevention in children undergoing low-risk CSF shunt surgery
- PMID: 38734598
- PMCID: PMC11088062
- DOI: 10.1186/s12887-024-04798-9
Antibiotic impregnated catheters and intrathecal antibiotics for CSF shunt infection prevention in children undergoing low-risk CSF shunt surgery
Abstract
Background: Cerebrospinal fluid (CSF) shunts allow children with hydrocephalus to survive and avoid brain injury (J Neurosurg 107:345-57, 2007; Childs Nerv Syst 12:192-9, 1996). The Hydrocephalus Clinical Research Network implemented non-randomized quality improvement protocols that were shown to decrease infection rates compared to pre-operative prophylactic intravenous antibiotics alone (standard care): initially with intrathecal (IT) antibiotics between 2007-2009 (J Neurosurg Pediatr 8:22-9, 2011), followed by antibiotic impregnated catheters (AIC) in 2012-2013 (J Neurosurg Pediatr 17:391-6, 2016). No large scale studies have compared infection prevention between the techniques in children. Our objectives were to compare the risk of infection following the use of IT antibiotics, AIC, and standard care during low-risk CSF shunt surgery (i.e., initial CSF shunt placement and revisions) in children.
Methods: A retrospective observational cohort study at 6 tertiary care children's hospitals was conducted using Pediatric Health Information System + (PHIS +) data augmented with manual chart review. The study population included children ≤ 18 years who underwent initial shunt placement between 01/2007 and 12/2012. Infection and subsequent CSF shunt surgery data were collected through 12/2015. Propensity score adjustment for regression analysis was developed based on site, procedure type, and year; surgeon was treated as a random effect.
Results: A total of 1723 children underwent initial shunt placement between 2007-2012, with 1371 subsequent shunt revisions and 138 shunt infections. Propensity adjusted regression demonstrated no statistically significant difference in odds of shunt infection between IT antibiotics (OR 1.22, 95% CI 0.82-1.81, p = 0.3) and AICs (OR 0.91, 95% CI 0.56-1.49, p = 0.7) compared to standard care.
Conclusion: In a large, observational multicenter cohort, IT antibiotics and AICs do not confer a statistically significant risk reduction compared to standard care for pediatric patients undergoing low-risk (i.e., initial or revision) shunt surgeries.
Keywords: Antibiotic impregnated catheter; CSF; Hydrocephalus; Infection.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Infection rates during eras of intrathecal antibiotic use followed by antibiotic-impregnated catheter use in prevention of cerebrospinal fluid shunt infection.J Neurosurg Pediatr. 2024 Jul 19;34(4):357-364. doi: 10.3171/2024.5.PEDS23372. Print 2024 Oct 1. J Neurosurg Pediatr. 2024. PMID: 39029119 Free PMC article.
-
Associations of Standard Care, Intrathecal Antibiotics, and Antibiotic-Impregnated Catheters With Cerebrospinal Fluid Shunt Infection Organisms and Resistance.J Pediatric Infect Dis Soc. 2023 Sep 27;12(9):504-512. doi: 10.1093/jpids/piad064. J Pediatric Infect Dis Soc. 2023. PMID: 37681670 Free PMC article.
-
Comparative effectiveness of antibiotic-impregnated shunt catheters in the treatment of adult and pediatric hydrocephalus: analysis of 12,589 consecutive cases from 287 US hospital systems.J Neurosurg. 2015 Feb;122(2):443-8. doi: 10.3171/2014.10.JNS13395. Epub 2014 Nov 21. J Neurosurg. 2015. PMID: 25415066
-
Route of antibiotic prophylaxis for prevention of cerebrospinal fluid-shunt infection.Cochrane Database Syst Rev. 2019 Jun 4;6(6):CD012902. doi: 10.1002/14651858.CD012902.pub2. Cochrane Database Syst Rev. 2019. PMID: 31163089 Free PMC article.
-
Cost-consequence analysis of antibiotic-impregnated shunts and external ventricular drains in hydrocephalus.J Neurosurg. 2015 Jan;122(1):139-47. doi: 10.3171/2014.9.JNS131277. J Neurosurg. 2015. PMID: 25380105 Review.
Cited by
-
Correct understanding of the definition and management strategies for refractory hydrocephalus.Chin Neurosurg J. 2025 Aug 18;11(1):16. doi: 10.1186/s41016-025-00403-9. Chin Neurosurg J. 2025. PMID: 40826122 Free PMC article. Review.
References
-
- Williams MA, McAllister JP, Walker ML, Kranz DA, Bergsneider M, Del Bigio MR, et al. Priorities for hydrocephalus research: report from a National Institutes of Health-sponsored workshop. J Neurosurg. 2007;107(5 Suppl):345–357. - PubMed
-
- Dewan MC, Rattani A, Mekary R, Glancz LJ, Yunusa I, Baticulon RE, et al. Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis. J Neurosurg. 2018;130(4):1065–79. 10.3171/2017.10.JNS17439. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical